{"nct_id":"NCT01938625","title":"A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation","status":"COMPLETED","status_verified_date":"2018-11","start_date":"2013-12-12","start_date_type":"ACTUAL","primary_completion_date":"2015-04-27","primary_completion_date_type":"ACTUAL","completion_date":"2015-07-28","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}